Longitudinal analysis of antibody response to immunization in paediatric survivors after allogeneic haematopoietic stem cell transplantation

British Journal of Haematology

Volumn 156, Issue 1, 2012, Pages 109-117

  Inaba, Hiroto ^a,b   Hartford, Christine M ^a   Pei, Deqing ^a   Posner, Meredith J ^a   Yang, Jie ^a   Hayden, Randall T ^a   Srinivasan, Ashok ^a,b   Triplett, Brandon M ^a,b   McCulllers, Jon A ^a,b   Pui, Ching Hon ^a,b   Leung, Wing ^a,b  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^b UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

Allogeneic; Childhood; Haematopoietic stem cell transplantation; Immunization; Survivor

Indexed keywords

ANTIBODY; DECAVAC; DIPHTHERIA PERTUSSIS TETANUS VACCINE; DIPHTHERIA TETANUS VACCINE; HAEMOPHILUS INFLUENZAE TYPE B VACCINE; HEPATITIS B VACCINE; IMMUNOGLOBULIN M; INFLUENZA VACCINE; MEASLES MUMPS RUBELLA VACCINE; PNEUMOCOCCUS VACCINE; POLIOMYELITIS VACCINE; RECOMBINANT HEPATITIS B VACCINE; UNCLASSIFIED DRUG;

ACUTE GRAFT VERSUS HOST DISEASE; ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ANTIBODY RESPONSE; ANTIBODY TITER; APLASTIC ANEMIA; ARTICLE; CD19 LYMPHOCYTE COUNT; CD3 LYMPHOCYTE COUNT; CD4 LYMPHOCYTE COUNT; CHILD; CHRONIC GRAFT VERSUS HOST DISEASE; CHRONIC MYELOID LEUKEMIA; CYTOMEGALOVIRUS; DIPHTHERIA; FEMALE; HEPATITIS B; HUMAN; IMMUNIZATION; IMMUNOPATHOLOGY; INFLUENZA; LONGITUDINAL STUDY; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MEASLES; MUMPS; MYELODYSPLASTIC SYNDROME; PEDIATRICS; PERTUSSIS; PNEUMOCOCCAL INFECTION; POLIOMYELITIS; PRESCHOOL CHILD; PRIORITY JOURNAL; PROSPECTIVE STUDY; RADIATION; RUBELLA; SCHOOL CHILD; SEROLOGY; SICKLE CELL ANEMIA; SURVIVOR; TETANUS;

ADOLESCENT; ADULT; ANTIBODIES, BACTERIAL; ANTIBODIES, NEUTRALIZING; ANTIBODIES, VIRAL; BACTERIAL INFECTIONS; BACTERIAL VACCINES; CHILD; CHILD, PRESCHOOL; FOLLOW-UP STUDIES; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; INFANT; OPPORTUNISTIC INFECTIONS; TRANSPLANTATION, HOMOLOGOUS; VIRAL VACCINES; VIRUS DISEASES; YOUNG ADULT;

EID: 83555165050     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2011.08913.x     Document Type: Article

References (39)

1. Ada, G. (2001) Advances in immunology - vaccines and vaccination. New England Journal of Medicine, 345, 1042-1053.
2. Amanna, I.J., Carlson, N.E. & Slifka, M.K. (2007) Duration of humoral immunity to common viral and vaccine antigens. New England Journal of Medicine, 357, 1903-1915.
3. Chen, X., Hale, G.A., Barfield, R., Benaim, E., Leung, W.H., Knowles, J., Horwitz, E.M., Woodard, P., Kasow, K., Yusuf, U., Behm, F.G., Hayden, R.T., Shurtleff, S.A., Turner, V., Srivastava, D.K. & Handgretinger, R. (2006) Rapid immune reconstitution after a reduced-intensity conditioning regimen and a CD3-depleted haploidentical stem cell graft for paediatric refractory haematological malignancies. British Journal of Haematology, 135, 524-532.
4. Christenson, B., Bottiger, M. & Heller, L. (1983) Mass vaccination programme aimed at eradicating measles, mumps, and rubella in Sweden: first experience. British Medical Journal (Clinical Research ed.), 287, 389-391.
5. Clark, D.A., Emery, V.C. & Griffiths, P.D. (2003) Cytomegalovirus, human herpesvirus-6, and human herpesvirus-7 in hematological patients. Seminars in Hematology, 40, 154-162.
6. Committee of Infectious Diseases (2006) Prevention of pertussis among adolescents: recommendations for use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccine. Pediatrics, 117, 965-978.
7. Copelan, E.A. (2006) Medical progress: hematopoietic stem-cell transplantation. New England Journal of Medicine, 354, 1813-1826.
8. Dykewicz, C.A., Jaffe, H.W. & Kaplan, J.E. (2000) Guidelines for preventing opportunistic infections among hematopoietic stem cell transplant recipients - recommendations of CDC, the Infectious Diseases Society of America, and the American Society of Blood and Marrow Transplantation. Biology of Blood and Marrow Transplantation, 6, 7-83.
9. Fallen, P.R., McGreavey, L., Madrigal, J.A., Potter, M., Ethell, M., Prentice, H.G., Guimaraes, A. & Travers, P.J. (2003) Factors affecting reconstitution of the T cell compartment in allogeneic haematopoietic cell transplant recipients. Bone Marrow Transplantation, 32, 1001-1014.
10. Friedman, T.M., Varadi, G., Hopely, D.D., Filicko, J., Wagner, J., Ferber, A., Martinez, J., Brunner, J., Grosso, D., McGuire, L., Korngold, R. & Flomenberg, N. (2001) Nonmyeloablative conditioning allows for more rapid T-cell repertoire reconstitution following allogeneic matched unrelated bone marrow transplantation compared to myeloablative approaches. Biology of Blood and Marrow Transplantation, 7, 656-664.
11. Hewlett, E.L. & Edwards, K.M. (2005) Pertussis - not just for kids. New England Journal of Medicine, 352, 1215-1222.
12. Jaffe, D., Papadopoulos, E.B., Young, J.W., O'Reilly, R.J., Prockop, S., Kernan, N.A., Jakubowski, A., Boulad, F., Perales, M.A., Castro-Malaspina, H. & Small, T.N. (2006) Immunogenicity of recombinant hepatitis B vaccine (rHBV) in recipients of unrelated or related allogeneic hematopoietic cell (HC) transplants. Blood, 108, 2470-2475.
13. Kimura, M., Kuno-Sakai, H., Sato, Y., Kamiya, H., Nii, R., Isomura, S., Horiuchi, K., Kato, T., Deguchi, M., Saikusa, H., Mortimer, E.A. & Cherry, J.D. (1991) A comparative trial of the reactogenicity and immunogenicity of Takeda acellular pertussis vaccine combined with tetanus and diphtheria toxoids. Outcome in 3- to 8-month-old infants, 9- to 23-month-old infants and children, and 24- to 30-month-old children. American Journal of Diseases of Children, 145, 734-741.
14. Leung, W., Ahn, H., Rose, S.R., Phipps, S., Smith, T., Gan, K., O'Connor, M., Hale, G.A., Kasow, K.A., Barfield, R.C., Madden, R.M. & Pui, C.H. (2007) A prospective cohort study of late sequelae of pediatric allogeneic hematopoietic stem cell transplantation. Medicine (Baltimore), 86, 215-224.
15. Ljungman, P., Engelhard, D., de la Camara, R., Einsele, H., Locasciulli, A., Martino, R., Ribaud, P., Ward, K. & Cordonnier, C. (2005) Vaccination of stem cell transplant recipients: recommendations of the Infectious Diseases Working Party of the EBMT. Bone Marrow Transplantation, 35, 737-746.
16. Ljungman, P., Cordonnier, C., Einsele, H., Englund, J., Machado, C.M., Storek, J. & Small, T. (2009) Vaccination of hematopoietic cell transplant recipients. Bone Marrow Transplantation, 44, 521-526.
17. Lougaris, V., Badolato, R., Ferrari, S. & Plebani, A. (2005) Hyper immunoglobulin M syndrome due to CD40 deficiency: clinical, molecular, and immunological features. Immunological Reviews, 203, 48-66.
18. Lum, L.G. (1987) The kinetics of immune reconstitution after human marrow transplantation. Blood, 69, 369-380.
19. Myers, M.G., Beckman, C.W., Vosdingh, R.A. & Hankins, W.A. (1982) Primary immunization with tetanus and diphtheria toxoids. Reaction rates and immunogenicity in older children and adults. JAMA, 248, 2478-2480.
20. Parkkali, T., Kayhty, H., Hovi, T., Olander, R.M., Roivainen, M., Volin, L., Ruutu, T., Lahdenkari, M. & Ruutu, P. (2007) A randomized study on donor immunization with tetanus-diphtheria, Haemophilus influenzae type b and inactivated poliovirus vaccines to improve the recipient responses to the same vaccines after allogeneic bone marrow transplantation. Bone Marrow Transplantation, 39, 179-188.
21. Patel, S.R., Ortin, M., Cohen, B.J., Borrow, R., Irving, D., Sheldon, J. & Heath, P.T. (2007) Revaccination with measles, tetanus, poliovirus, Haemophilus influenzae type B, meningococcus C, and pneumococcus vaccines in children after hematopoietic stem cell transplantation. Clinical Infectious Diseases, 44, 625-634.
22. Plotkin, S.A. (2001) Immunologic correlates of protection induced by vaccination. Pediatric Infectious Disease Journal, 20, 63-75.
23. Salk, J., van Wezel, A.L., Stoeckel, P., van Steenis, G., Schlumberger, M., Meyran, M., Rey, J.L., Lapinleimu, K., Bottiger, M. & Cohen, H. (1981) Theoretical and practical considerations in the application of killed poliovirus vaccine for the control of paralytic poliomyelitis. Developments in Biological Standardization, 47, 181-198.
24. Schiff, G.M., Sherwood, J.R., Zeldis, J.B. & Krause, D.S. (1995) Comparative study of the immunogenicity and safety of two doses of recombinant hepatitis B vaccine in healthy adolescents. Journal of Adolescent Health, 16, 12-17.
25. Small, T. (2007) Vaccination of children following allogeneic: stem cell transplantation. Biology of Blood and Marrow Transplantation, 14, 54-58.
26. Socie, G., Salooja, N., Cohen, A., Rovelli, A., Carreras, E., Locasciulli, A., Korthof, E., Weis, J., Levy, V. & Tichelli, A. (2003) Nonmalignant late effects after allogeneic stem cell transplantation. Blood, 101, 3373-3385.
27. Spoulou, V., Giannaki, M., Vounatsou, M., Bakoula, C. & Grafakos, S. (2004) Long-term immunity to measles, mumps and rubella after MMR vaccination among children with bone marrow transplants. Bone Marrow Transplantation, 33, 1187-1190.
28. Storek, J., Wells, D., Dawson, M.A., Storer, B. & Maloney, D.G. (2001a) Factors influencing B lymphopoiesis after allogeneic hematopoietic cell transplantation. Blood, 98, 489-491.
29. Storek, J., Joseph, A., Espino, G., Dawson, M.A., Douek, D.C., Sullivan, K.M., Flowers, M.E., Martin, P., Mathioudakis, G., Nash, R.A., Storb, R., Appelbaum, F.R. & Maloney, D.G. (2001b) Immunity of patients surviving 20 to 30years after allogeneic or syngeneic bone marrow transplantation. Blood, 98, 3505-3512.
30. Storek, J., Joseph, A., Dawson, M.A., Douek, D.C., Storer, B. & Maloney, D.G. (2002) Factors influencing T-lymphopoiesis after allogeneic hematopoietic cell transplantation. Transplantation, 73, 1154-1158.
31. Storek, J., Viganego, F., Dawson, M.A., Herremans, M.M., Boeckh, M., Flowers, M.E., Storer, B., Bensinger, W.I., Witherspoon, R.P. & Maloney, D.G. (2003) Factors affecting antibody levels after allogeneic hematopoietic cell transplantation. Blood, 101, 3319-3324.
32. Styczynski, J. & Gil, L. (2008) Prevention of infectious complications in pediatric HSCT. Bone Marrow Transplantation, 42, S77-S81.
33. Tomblyn, M., Chiller, T., Einsele, H., Gress, R., Sepkowitz, K., Storek, J., Wingard, J.R., Young, J.A. & Boeckh, M.A. (2009) Guidelines for preventing infectious complications among hematopoietic cell transplantation recipients: a global perspective. Biology of Blood and Marrow Transplantation, 15, 1143-1238.
34. Watson, J.C., Pearson, J.A., Markowitz, L.E., Baughman, A.L., Erdman, D.D., Bellini, W.J., Baron, R.C. & Fleming, D.W. (1996) An evaluation of measles revaccination among school-entry-aged children. Pediatrics, 97, 613-618.
35. Weibel, R.E., Stokes, Jr, J., Buynak, E.B., Whitman, Jr, J.E. & Hilleman, M.R. (1967) Live attenuated mumps-virus vaccine. 3. Clinical and serologic aspects in a field evaluation. New England Journal of Medicine, 276, 245-251.
36. Weinberg, K., Annett, G., Kashyap, A., Lenarsky, C., Forman, S.J. & Parkman, R. (1995) The effect of thymic function on immunocompetence following bone marrow transplantation. Biology of Blood and Marrow Transplantation, 1, 18-23.
37. Weinberg, K., Blazar, B.R., Wagner, J.E., Agura, E., Hill, B.J., Smogorzewska, M., Koup, R.A., Betts, M.R., Collins, R.H. & Douek, D.C. (2001) Factors affecting thymic function after allogeneic hematopoietic stem cell transplantation. Blood, 97, 1458-1466.
38. Williams, K.M. & Gress, R.E. (2008) Immune reconstitution and implications for immunotherapy following haematopoietic stem cell transplantation. Best Practice & Research Clinical Haematology, 21, 579-596.
39. Witherspoon, R.P., Storb, R., Ochs, H.D., Fluornoy, N., Kopecky, K.J., Sullivan, K.M., Deeg, J.H., Sosa, R., Noel, D.R., Atkinson, K. & Thomas, E.D. (1981) Recovery of antibody production in human allogeneic marrow graft recipients: influence of time posttransplantation, the presence or absence of chronic graft-versus-host disease, and antithymocyte globulin treatment. Blood, 58, 360-368.